Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
StockNews.AI · 2 hours
AI Summary
Zealand Pharma published a regulatory update confirming 71,578,758 shares and voting rights as of June 30, 2026. It notes a June 8 capital increase from employee warrants, with no further changes by month-end. The announcement is routine and unlikely to meaningfully affect near-term price or fundamentals.
Sentiment Rationale
The release is a standard governance disclosure about outstanding shares and voting rights, not a new financing, product update, or earnings catalyst. Similar disclosures historically show limited price impact beyond confirming existing capitalization and any past dilution from warrants.
Trading Thesis
Neutral near-term; routine cap table update unlikely to drive ZEAL price.
Market-Moving
- Routine cap-table disclosure; no new financing or major dilution implied.
- No change in voting rights post June 30; supports stability.
- ZEAL's focus on obesity/metabolic health remains the primary catalyst.
Key Facts
- Zealand Pharma reports June 30, 2026 shares and voting rights: 71,578,758.
- Share capital also 71,578,758 DKK; nominal value equals share count.
- Announcement notes June 8 warrant exercise caused capital increase.
- Regulatory update is routine; no new financing implied.
- ZEAL remains focused on obesity/metabolic health using AI/ML.
Companies Mentioned
- Zealand Pharma A/S (ZEAL): Regulatory update confirms total shares and voting rights; confirms cap-table as of 2026-06-30.
Corporate Developments
Category: Corporate Developments. This is a routine regulatory cap-table update tied to warrants activity, with minimal immediate impact on fundamentals or valuation.